82 related articles for article (PubMed ID: 15608972)
1. [Oligodendroglial and neuronal component in glioblastomas: possible relation with prognosis].
Pinto LW; Chimelli L
Arq Neuropsiquiatr; 2004 Dec; 62(4):1074-8. PubMed ID: 15608972
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic alterations in glioblastomas with oligodendroglial component.
Kraus JA; Lamszus K; Glesmann N; Beck M; Wolter M; Sabel M; Krex D; Klockgether T; Reifenberger G; Schlegel U
Acta Neuropathol; 2001 Apr; 101(4):311-20. PubMed ID: 11355302
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.
Joseph NM; Phillips J; Dahiya S; M Felicella M; Tihan T; Brat DJ; Perry A
Mod Pathol; 2013 Mar; 26(3):315-26. PubMed ID: 23041832
[TBL] [Abstract][Full Text] [Related]
4. Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.
Hilton DA; Penney M; Pobereskin L; Sanders H; Love S
Histopathology; 2004 Jun; 44(6):555-60. PubMed ID: 15186270
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
6. Glioblastomas with an oligodendroglial component: a pathological and molecular study.
He J; Mokhtari K; Sanson M; Marie Y; Kujas M; Huguet S; Leuraud P; Capelle L; Delattre JY; Poirier J; Hoang-Xuan K
J Neuropathol Exp Neurol; 2001 Sep; 60(9):863-71. PubMed ID: 11556543
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of neuronal marker expression in glioblastomas.
Lee KH; Kang KJ; Moon KS; Jung TY; Jung S; Kim JH; Kim HS; Lee MC
Childs Nerv Syst; 2012 Nov; 28(11):1879-86. PubMed ID: 22922887
[TBL] [Abstract][Full Text] [Related]
8. Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.
Klink B; Schlingelhof B; Klink M; Stout-Weider K; Patt S; Schrock E
Cell Oncol (Dordr); 2011 Jun; 34(3):261-75. PubMed ID: 21538026
[TBL] [Abstract][Full Text] [Related]
9. Expression of diagnostic neuronal markers and outcome in glioblastoma.
Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476
[TBL] [Abstract][Full Text] [Related]
10. Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.
Elmahdi A; Frary AJ; Scotton WJ; O'Donovan DG; Price SJ
Br J Neurosurg; 2013 Aug; 27(4):419-24. PubMed ID: 23418780
[TBL] [Abstract][Full Text] [Related]
11. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.
Donahue B; Scott CB; Nelson JS; Rotman M; Murray KJ; Nelson DF; Banker FL; Earle JD; Fischbach JA; Asbell SO; Gaspar LE; Markoe AM; Curran W
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):911-4. PubMed ID: 9276354
[TBL] [Abstract][Full Text] [Related]
12. [Morphological classification of glioblastomas].
Figarella-Branger D; Bouvier C; Moroch J; Michalak S; F Burel-Vandenbos
Neurochirurgie; 2010 Dec; 56(6):459-63. PubMed ID: 20864138
[TBL] [Abstract][Full Text] [Related]
13. Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy.
Decaestecker C; Camby I; Gordower L; Dewitte O; Cras P; Martin JJ; Pasteels JL; Van Ham P; Brotchi J; Kiss R; Salmon I
J Neuropathol Exp Neurol; 1998 Aug; 57(8):791-802. PubMed ID: 9720494
[TBL] [Abstract][Full Text] [Related]
14. alpha-Internexin expression identifies 1p19q codeleted gliomas.
Ducray F; Crinière E; Idbaih A; Mokhtari K; Marie Y; Paris S; Navarro S; Laigle-Donadey F; Dehais C; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
Neurology; 2009 Jan; 72(2):156-61. PubMed ID: 19139367
[TBL] [Abstract][Full Text] [Related]
15. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H
J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
[TBL] [Abstract][Full Text] [Related]
16. [Differentiation in primitive neuroectodermal tumors. Significance of histology and immunohistochemistry for differential diagnosis].
Grieshammer T
Zentralbl Pathol; 1991; 137(1):57-65. PubMed ID: 1647814
[TBL] [Abstract][Full Text] [Related]
17. [Glioblastomas: clinical study and search for prognostic factors].
Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma with oligodendroglial components: glioblastoma or anaplastic oligodendroglial tumors.
Takeuchi H; Hosoda T; Kitai R; Kodera T; Arishima H; Tsunetoshi K; Neishi H; Yamauchi T; Sato K; Imamura Y; Itoh H; Kubota T; Kikuta K
Brain Tumor Pathol; 2012 Jul; 29(3):154-9. PubMed ID: 22527749
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.
Ducray F; Mokhtari K; Crinière E; Idbaih A; Marie Y; Dehais C; Paris S; Carpentier C; Dieme MJ; Adam C; Hoang-Xuan K; Duyckaerts C; Delattre JY; Sanson M
Eur J Cancer; 2011 Mar; 47(5):802-8. PubMed ID: 21194923
[TBL] [Abstract][Full Text] [Related]
20. FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status.
Kaloshi G; Mokhtari K; Carpentier C; Taillibert S; Lejeune J; Marie Y; Delattre JY; Godbout R; Sanson M
J Neurooncol; 2007 Sep; 84(3):245-8. PubMed ID: 17415524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]